PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAgile Therapeutics
Agile Therapeutics(AGRX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
TwirlaEthinyl estradiol, Levonorgestrel2020-02-142023-2039
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Uterine hemorrhage
,
Contraception
,
Primary ovarian insufficiency
,
Amenorrhea
,
Hot flashes
,
Hypogonadism
,
Premature menopause
,
Acne vulgaris
,
Endometriosis
,
Endometrial hyperplasia
,
Menstruation disturbances
,
Female infertility
,
Folic acid deficiency
,
Megaloblastic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ethinyl estradiol
vision disorders
,
ovulation inhibition
,
healthy volunteers/patients
,
contraception
Levonorgestrel
postcoital contraception
,
biological availability
,
pharmacokinetics
,
drug interactions
,
castration-resistant prostatic neoplasms
,
endometriosis
,
unplanned pregnancy
,
dysmenorrhea
,
endometrial hyperplasia
,
headache
,
pelvic pain
,
libido
,
menopause
,
contraception
,
menorrhagia
,
hemorrhage
,
healthy volunteers/patients
,
medicated intrauterine devices
,
uterine hemorrhage
,
hot flashes
,
epilepsy
,
breast neoplasms
,
intrauterine devices
,
uterine perforation
,
postmenopause
,
venous thromboembolism
,
thromboembolism
,
pregnancy
,
amenorrhea
,
microbiota
,
metagenome
,
hyperplasia
,
estrogen replacement therapy
,
osteoporosis
,
postmenopausal osteoporosis
Microgynon
healthy volunteers/patients
Trinessa
erectile dysfunction
,
torsades de pointes
Fluoroquinolone
chronic obstructive pulmonary disease
,
respiratory aspiration
,
healthy volunteers/patients
,
coronary artery disease
,
electrocardiography
,
overactive urinary bladder
,
endometriosis
,
cough
,
hot flashes
,
multiple endocrine neoplasia type 1
,
cystic fibrosis
,
tuberculosis
,
infections
,
communicable diseases
,
intraabdominal infections
,
sepsis
,
bronchiectasis
,
lung diseases
,
abdominal abscess
,
pelvic infection
,
pelvic inflammatory disease
,
diabetic foot
,
wound infection
,
ulcer
,
aspiration pneumonia
,
lung abscess
,
contraception
,
septic shock
,
respiratory tract infections
,
cholera
,
acute cholecystitis
,
healthcare-associated pneumonia
,
bacterial pneumonia
,
neurologic manifestations
,
joint diseases
,
acquired joint deformities
,
burns
,
hematologic diseases
,
febrile neutropenia
,
neutropenia
,
neoplasms
,
fever
,
pneumonia
,
chronic bronchitis
,
bronchitis
,
urinary tract infections
,
sinusitis
,
abscess
,
community-acquired pneumonia
,
bacterial infections
,
acute disease
,
pseudomonas infections
,
liver abscess
,
pyogenic liver abscess
,
maxillary sinusitis
,
rhinosinusitis
,
peritonitis
,
anthrax
,
disease progression
,
cholecystitis
,
cholangitis
,
wounds and injuries
,
chemical and drug induced liver injury
,
tonsillitis
,
bacterial skin diseases
,
bronchial diseases
,
pyelonephritis
,
cystitis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use